venBio Partners’s Alumis Inc ALMS Stock Holding History

venBio Partners’s Portfolio ALMS Stock Details ALMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$99.8M	Sell	4,528,408 -91,395	-2%	-$2.28M	35.56%	2
2025 Q4	$45.1M	Hold	4,619,803	–	–	20.85%	2
2025 Q3	$18.4M	Hold	4,619,803	–	–	10.45%	2
2025 Q2	$13.9M	Buy	4,619,803 +1,832,405	+66%	+$8.65M	12.08%	3
2025 Q1	$17.1M	Hold	2,787,398	–	–	13.85%	2
2024 Q4	$21.9M	Sell	2,787,398 -38,650	-1%	-$387K	12.83%	2
2024 Q3	$30.2M	Hold	2,826,048	–	–	15.53%	2
2024 Q2	$37.6M	Buy	+2,826,048	New	+$37.6M	16.23%	3

Other funds holding ALMS

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return